Brian Hess to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Brian Hess has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.337
-
Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study. Am J Hematol. 2023 02; 98(2):300-308.
Score: 0.167
-
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure. Cancer. 2020 01 15; 126(2):293-303.
Score: 0.133
-
Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma. Clin Cancer Res. 2021 06 15; 27(12):3339-3350.
Score: 0.037